1. Home
  2. TELA vs INCR Comparison

TELA vs INCR Comparison

Compare TELA & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

HOLD

Current Price

$0.71

Market Cap

41.3M

Sector

Health Care

ML Signal

HOLD

Logo Intercure Ltd.

INCR

Intercure Ltd.

HOLD

Current Price

$1.04

Market Cap

47.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TELA
INCR
Founded
2012
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.3M
47.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
TELA
INCR
Price
$0.71
$1.04
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
91.2K
66.3K
Earning Date
05-12-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
37.59
N/A
EPS
N/A
N/A
Revenue
$80,275,000.00
N/A
Revenue This Year
$10.23
$69.54
Revenue Next Year
$14.26
$41.75
P/E Ratio
N/A
N/A
Revenue Growth
15.84
N/A
52 Week Low
$0.50
$0.68
52 Week High
$2.19
$1.77

Technical Indicators

Market Signals
Indicator
TELA
INCR
Relative Strength Index (RSI) 41.10 56.76
Support Level $0.73 $0.84
Resistance Level $0.94 $1.23
Average True Range (ATR) 0.10 0.07
MACD -0.02 0.00
Stochastic Oscillator 26.85 61.30

Price Performance

Historical Comparison
TELA
INCR

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: